Cargando…
Development of a UPLC-MS/MS method for the therapeutic monitoring of L-asparaginase
This study aimed to develop a UPLC-MS/MS method for determining plasma levels of L-aspartic acid and L-asparagine and the activity of L-asparaginase. L-aspartic acid, L-asparagine, and L-aspartic acid-2,3,3-d(3) were extracted from human plasma by protein precipitation with sulfosalicylic acid (30%,...
Autores principales: | Jeong, Hyeon-Cheol, Kim, Therasa, Yang, Deok-Hwan, Shin, Kwang-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Clinical Pharmacology and Therapeutics
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989229/ https://www.ncbi.nlm.nih.gov/pubmed/32055563 http://dx.doi.org/10.12793/tcp.2018.26.3.134 |
Ejemplares similares
-
Determination of candesartan or olmesartan in hypertensive patient plasma using UPLC-MS/MS
por: Jeong, Hyeon-Cheol, et al.
Publicado: (2021) -
Bioanalytical methods for the detection of duloxetine and thioctic acid in plasma using ultra performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS)
por: Wei, Zhuodu, et al.
Publicado: (2022) -
Validated UPLC-MS/MS method for the determination of tadalafil in human plasma and its application to a pharmacokinetic study
por: Kim, Kwang-Youl, et al.
Publicado: (2017) -
Determination of Osimertinib, Aumolertinib, and Furmonertinib in Human Plasma for Therapeutic Drug Monitoring by UPLC-MS/MS
por: Li, Ying, et al.
Publicado: (2022) -
Development of a UPLC–MS/MS method for simultaneous therapeutic drug monitoring of anti-hepatocellular carcinoma drugs and analgesics in human plasma
por: Lu, Shijia, et al.
Publicado: (2023)